Now, the debate has turned to the impact of the proposed rule, which is more aggressive than some anticipated. A Treasury ...

Ahead of its FDA approval decision on Nov 30, Vertex's kidney disease drug is being heavily scrutinized for infection risk.

For years, scientists have struggled to elucidate key biological differences between early onset colorectal cancer, typically ...

Eli Lilly announced that its investigational drug retatrutide was more effective at lowering blood sugar and cutting weight ...

Abdul El-Sayed has made headlines for his progressive politics and stance on Israel. But some supporters consider his public ...

After years of steep increases, especially amid the pandemic, U.S. overdose deaths decreased 27% in 2024, and preliminary ...

Missouri attorney general warned Eli Lilly to discontinue requiring hospitals to provide claims data to receive discounted ...

This is the web edition of STAT’s AI Prognosis newsletter, our guide to artificial intelligence in health care and medicine.

A House lawmaker asked the Government Accountability Office to review whether the TrumpRx platform has saved Americans any ...

Kennedy and his MAHA movement have embraced peptides, though there's little evidence for many of the wellness compounds.

A STAT investigation found that Epic selectively withholds access to patient data, disadvantaging rival software developers and stymying innovation.

Recent deaths are setbacks in drug companies’ interest in applying cancer therapy strategies to autoimmune diseases.